- Home
- ZBIO
ZBIO
ZENAS BIOPHARMA INC
as 10-24-2024 4:00pm EST
Stocks
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $36.75 | AVG Volume (30 days): | 158.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.17 - $26.11 | Next Earning Date: | 11-16-2024 |
| Revenue: | $50,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ZENAS BIOPHARMA INC News
ZBIO Breaking Stock News: Dive into ZBIO Ticker-Specific Updates for Smart Investing
TipRanks
10 days ago
Opening Day: Another trio of biotech IPOs make Friday debut
GlobeNewswire
a month ago
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Share on Social Networks:
Disclaimer
The information presented on this page, "ZBIO ZENAS BIOPHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.